Trental

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Aktīvā sastāvdaļa:

Pentoxifylline 400mg;  ;  

Pieejams no:

Clinect NZ Pty Limited

SNN (starptautisko nepatentēto nosaukumu):

Pentoxifylline 400 mg

Deva:

400 mg

Zāļu forma:

Modified release tablet

Kompozīcija:

Active: Pentoxifylline 400mg     Excipient: Erythrosine Hyetellose Hypromellose Macrogol 8000 Magnesium stearate Povidone Purified talc   Purified water   Titanium dioxide

Vienības iepakojumā:

Blister pack, PVC/Al, 50 tablets

Klase:

Prescription

Receptes veids:

Prescription

Ražojis:

Sanofi India Limited

Ārstēšanas norādes:

The treatment of peripheral occlusive vascular disease and circulatory disorders of arteriosclerotic, diabetic, inflammatory or function origin; trophic disorders (e.g., leg ulcers and gangrene).

Produktu pārskats:

Package - Contents - Shelf Life: Blister pack, PVC/Al - 50 tablets - 36 months from date of manufacture stored at or below 25°C

Autorizācija datums:

2001-11-16

Lietošanas instrukcija

TRENTAL
®
400
1
TRENTAL
®
_Pentoxifylline _
CONSUMER MEDICINE INFORMATION (CMI)
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Trental.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you taking this medicine
against the benefits they expect it
will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT TRENTAL IS USED
FOR
Trental is a type of medicine used to
improve the circulation of the blood.
Trental is used to treat the symptoms
of:
•
A CONDITION CALLED PERIPHERAL
OCCLUSIVE VASCULAR DISEASE.
SYMPTOMS OF THIS DISEASE CAN
INCLUDE LAMENESS AND PAIN,
USUALLY IN THE LEG MUSCLES.
•
CIRCULATORY DISORDERS CAUSED BY
THICKENING OF THE BLOOD VESSEL
WALLS, DIABETICS, INFLAMMATION,
LEG ULCERS AND GANGRENE.
•
CIRCULATORY DISORDERS IN THE EYE
AND YEAR WHICH HAVE RESULTED IN
A DECREASE IN SIGHT AND/OR
HEARING FUNCTION.
Trental is a slow release tablet, which
means that the active ingredient is
released slowly over several hours.
Your doctor, however, may prescribe
Trental for another purpose.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY IT HAS BEEN
PRESCRIBED FOR YOU.
This medicine is only available with
a doctor's prescription.
BEFORE YOU TAKE IT
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE TRENTAL IF YOU HAVE:
•
had a recent operation
•
bleeding problems
•
heart problems, such as having
suffered a heart attack
•
kidney or liver problems
•
stomach ulcers or a history of
stomach ulcers
•
had an allergic reaction to
caffeine, theobromine or
theophylline (a medicine used to
treat asthma)
DO NOT TAKE TRENTAL IF YOU ARE
ALLERGIC TO IT OR ANY OF THE
INGREDIENTS LISTED AT THE END OF THIS
LEAFLET.
Some symptoms of an allergic
reaction include skin rash, itching,
shortness of breath or swelling of the
face, lips or tongue, w

Produkta apraksts

1
NEW ZEALAND DATA SHEET
1.
TRENTAL 400 MG MODIFIED RELEASE TABLETS
Trental 400 mg modified release tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pentoxifylline 400 mg.
Oxpentifylline and Pentoxifylline are interchangeable and refer to the
same molecule.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Modified release tablet.
Oblong, pink, film-coated tablets.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Trental is indicated in the treatment of peripheral occlusive vascular
disease and circulatory disorders of
arteriosclerotic, diabetic, inflammatory or function origin; trophic
disorders (e.g., leg ulcers and gangrene).
Circulatory disorders in the eye and ear associated with degenerative
vascular processes resulting in a
decrease of visual and auditory function.
4.2 DOSE AND METHOD OF ADMINISTRATION
_DOSE _
The usual dosage of Trental in controlled release tablet form is one
tablet (400 mg) three times a day with or
after meals, to be swallowed whole with some liquid. While the effect
of Trental may be seen within 2-4
weeks, it is recommended that treatment be continued for at least 8
weeks. Efficacy has been demonstrated
in double blind clinical studies of 6 months duration.
Digestive and central nervous system side effects are dose related. If
patients develop these side effects it
is recommended that dosage be lowered to one tablet twice a day
(800mg/day). If side effects persist at this
lower dosage the administration of Trental should be discontinued.
In patients with low or labile blood pressure, or with renal or
hepatic dysfunction, an individual dosage
adjustment is required. This also applies to patients with renal
dysfunction (creatinine clearance of less than
30 mL/min) where, according to individual tolerance, a dosage
adjustment of 30 to 50% may be necessary.
PAEDIATRIC POPULATION
Trental is not recommended for children.
_METHOD OF ADMINISTRATION _
Oral administration.
Tablets should be taken with or immediately after meals, and swallowed
whole with some liquid.